Medmix Ltd
SIX:MEDX

Watchlist Manager
Medmix Ltd Logo
Medmix Ltd
SIX:MEDX
Watchlist
Price: 8.68 CHF 2.12% Market Closed
Market Cap: CHf358.1m

Medmix Ltd
Investor Relations

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.

Show more
Loading
MEDX
Swiss Market Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 26, 2026
Q4 2025 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls
2025
2023

Management

Ms. Jennifer Dean
Chief Financial Officer
No Bio Available
Ms. Sheel Gill
Head of M&A, Strategy & Investor Relations
No Bio Available
Mr. Schops Xavier
Chief Legal Officer, Company Secretary & Head of Corporate Affairs
No Bio Available
Ms. Itee Satpathy
Chief Human Resources & Sustainability Officer
No Bio Available

Contacts

Address
ZUG
Zug
Dammstrasse 19
Contacts
+41417237300
www.medmix.ch
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett